Meeting Coverage >

ACC

TEER Improves Quality of Life With Severe Tricuspid Regurgitation

Pivotal trial is first to evaluate "impact of TR reduction on long-term effects on survival"

Bempedoic Acid Proves Clinical Benefits for the Statin-Intolerant

Yet the good clinical data are complicated by real-world cost and access problems

Atorvastatin Tied to Cardioprotection for Lymphoma Patients on Anthracyclines

STOP-CA deemed "an impactful study that will lead to more prescription of statins in patients."

Gender Affirmation Hormones Come With Cardiovascular Tradeoffs

National hospital data add to the literature on HRT's risk-benefit profile

Anticoagulation Goes Head-to-Head With DAPT After Valve Surgery

Edoxaban not significantly better for thrombosis protection in "underpowered" ADAPT-TAVR trial

Two PCI Guidance Strategies on Par for Intermediate Coronary Stenosis

FLAVOUR trial weighs in on FFR versus IVUS

Which Drug-Coated Balloon Proved Superior in Peripheral Artery Disease?

Second-generation device goes head-to-head with popular first-gen device

Cardiac Monitoring Finds Arrhythmias, but Treatment Did Not Improve Outcomes

No differences in mortality, hospitalization between monitored patients and control patients

TAVR Valve Outlasts Surgical Bioprostheses at 5 Years

No longer assume that TAVR bioprostheses are inherently less durable

Study Provides 'Elusive' Link Between Kids' Health and Adult Heart Events

CV risk factors in childhood tied to midlife CV events and CVD

Patiromer Limits Impact of RAAS Inhibitor-Related Hyperkalemia in HF

Patients better able to achieve target dose of mineralocorticoids and angiotensin inhibitors

Transcatheter Tricuspid Repair Shows Early Promise

PASCAL device safe and linked to symptom improvement in severe tricuspid regurgitation

Extra Warming Efforts in Surgery Turn Out to Be Hot Air

PROTECT trial finds targeting body temperatures a few degrees higher is unnecessary

Flu Vaccine Didn't Stop Vascular Events in Heart Failure Patients

But study in lower income countries sees hint of benefit during peak disease season

Shoppers Adhered to Heart-Healthy Diet in Novel Program

Researchers teamed with supermarket chain to improve DASH scores

Don't Wait, Ablate to Prevent VT Episodes After an ICD Shock?

Early catheter ablation reduced deaths and ICD shocks in PARTITA trial

EHR Pop-Ups Spur Better GDMT Implementation in Heart Failure

Alert-based intervention in PROMPT-HF trial said to be low-cost, scalable

Higher-Dose ANGPTL3 Inhibitor Cuts Lipids but With Questionable Safety

Significant safety signals in dose-ranging trial may end drug's future in CV prevention

Add-On Mavacamten Cuts Need for Septal Reduction in Obstructive HCM

VALOR-HCM trial shows novel cardiac myosin inhibitor beneficial as targeted treatment

Tide Turns on Withholding Blood Pressure Meds for Pregnant Women

Antihypertensive treatment was safe for mothers and children in the CHAP trial

Low-Salt Diet Helpful for HF Symptoms, but Not Necessarily for Clinical Events

Sodium restriction still holds its ground in SODIUM-HF trial

Tranexamic Acid Cuts Surgical Bleeding in Yet Another Setting

But POISE-3 trial leaves open the question of cardiovascular safety

From 'Pre-HF' to 'HFimpEF': Guidelines Redefine Heart Failure Stages, Classes

Update also adds SGLT2 inhibitor as a pillar of therapy

In-Person ACC Meeting Returns, Serving Diet Intervention Studies and More

Will salt restriction finally get a boost at this weekend's meeting?

Xarelto Flops for COVID-19 Clot Prevention Outside ICU

ACTION trial adds nuance to the story from large platform trials

Burnout in Cardiology; Restrictive Transfusion Foiled; and Other News From ACC

Highlights from the scientific program of the American College of Cardiology meeting

Setbacks for Invasive Strategy, Moderate Cooling in Cardiac Arrest

Prague OHCA study, CAPITAL CHILL give some answers for out-of-hospital cardiac arrest treatment

Falling Through the Cracks on Rapid Troponin Testing Protocols

Studies point to potential risks and pitfalls with change to more sensitive, rapid testing

Novel Heart Failure Agent Works Best in Sickest Patients

Omecamtiv mecarbil provides benefit to those with low LVEF

Plavix Beats Aspirin, Brilinta After Stenting

HOST-EXAM and TALOS-AMI studies from South Korea focus on aspects of DAPT

Finerenone May Delay AFib Onset in Patients With CKD and Diabetes

Risk of kidney or CV events reduced regardless of atrial fibrillation or atrial flutter history

Entresto Risky for Advanced Heart Failure?

LIFE trial "not only disappointed but surprised" with its findings

Stubborn Gaps in Heart Failure Persist Despite Clinician Education, Feedback

Guideline-directed medical therapy underuse still a problem in CONNECT-HF trial

Antifibrotic Drug Shows Promise in HFpEF

PIROUETTE trial provides early proof

Personalized Rehab Helpful in Heart Failure Patients

Trial showed improvements in physical functioning and quality of life compared with usual care

DARE-19 Didn't Pay Off for Farxiga in COVID-19

But trial may still show SGLT2 inhibitor is safe for sicker patients

Renal Denervation Shows Worth in Resistant Hypertension

Catheter-based procedure gets a win in RADIANCE-HTN TRIO

A Call for Nuance in Cardioprotection With Early Breast Cancer Therapy

Longer-term PRADA trial results weigh in for low-risk group

FFR Disappoints as Guide for PCI on Non-Culprit Lesions in STEMI

Angiography-guided strategy holds strong in FLOWER-MI trial

LAA Occlusion During Surgery Cuts Stroke Risk

Afib patients on antithrombotic therapy saw gains from add-on left atrial appendage occlusion

1